Remote Controlled Analgesia on Patient Experience (R-CAPE)

April 1, 2020 updated by: University Hospital, Montpellier

Effect of Perineural Catheter Analgesia on Patient Experience After Orthopedic Surgery

The main objective of this study is to compare the efficacy of continuous nerve blocks with single injection in terms of perioperative patient satisfaction after scheduled orthopedic ambulatory surgery. Subgroup analyses will be performed, a priori, according to patients Pain Catastrophizing Scale (PCS) and type of surgery.

Secondary objectives comprise the assessment of pain, readmission rates, patient mobilization, quality of sleep and heart rate collected by an activity tracker. Scales about quality of recovery will be performed on day 1, about quality of life on day 45 and presence of neuropathic pain will be screened at 3 months. An economic study will also be conducted, including work resumption at 3 months.

This is a multicentric prospective study. Three hundred patients will be randomized in two parallel groups: continuous nerve blocks delivered thru remote-controlled electronic pump versus single local anesthetics injection.

The primary endpoint is the EVAN-G patient satisfaction scale, scored at day 2. Secondary endpoints will include assessment of pain, opiates consumption, sensitivity and motricity scores, rate of catheter falls at home, hospital readmission, patient mobilization, sleep and heart rate as assessed by an activity tracker, PCS before the surgery and Quality of Recovery (QoR-40) scale at day 1, Short-Form 36 (SF36) at day 45 and Neuropathic Pain assessment (DN4) at day 90.

Study Overview

Detailed Description

Acute postoperative pain is poorly treated. More than three-quarters of patients complain of pain, from moderate to extreme, after surgery. In orthopedic surgery, continuous nerve blocks analgesia has proved effective among in-hospital patients but single injection strategy is easier to implement in the growing outpatient setting.

The main objective of this study is to compare the efficacy of continuous nerve blocks with single injection in terms of perioperative patient satisfaction after scheduled orthopedic ambulatory surgery. Subgroup analyses will be performed, a priori, according to patients Pain Catastrophizing Scale (PCS) and type of surgery.

Secondary objectives comprise the assessment of pain, readmission rates, patient mobilization, quality of sleep and heart rate collected by an activity tracker. Scales about quality of recovery will be performed on day 1, about quality of life on day 45 and presence of neuropathic pain will be screened at 3 months. An economic study will also be conducted, including work resumption at 3 months.

The inclusion criteria are adults undergoing outpatient scheduled orthopedic surgery under general anesthesia with regional analgesia.

Non-inclusion criteria are patients over 80 years, documented cognitive impairment, inability to complete a self-administered questionnaire, presenting American Society of Anesthesiology (ASA) physical status 3 unsteady or 4, or spontaneously requiring analgesic perineural catheter or a single injection of local anesthetics.

This is a multicentric prospective study. Three hundred patients will be randomized in two parallel groups: continuous nerve blocks delivered thru remote-controlled electronic pump versus single local anesthetics injection.

The primary endpoint is the EVAN-G patient satisfaction scale, scored at day 2. Secondary endpoints will include assessment of pain, opiates consumption, sensitivity and motricity scores, rate of catheter falls at home, hospital readmission, patient mobilization, sleep and heart rate as assessed by an activity tracker, PCS before the surgery and Quality of Recovery (QoR-40) scale at day 1, Short-Form 36 (SF36) at day 45 and Neuropathic Pain assessment (DN4) at day 90.

Study Type

Interventional

Enrollment (Actual)

300

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Montpellier, France, 34295
        • Department of Anesthesiology and critical care, Lapeyronie University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Male or female subject aged 18 or more, up to 80 years;
  • Undergoing potentially painful scheduled orthopedic surgery under general anesthesia.
  • Eligible to outpatient care;
  • Respecting the ambivalence clause defined below:

    1. no cons-indication to analgesic perineural catheter;
    2. not known allergy to local anesthetics;
    3. likely to be a candidate for continuous nerve block analgesia;
  • Ability to complete a self-reported questionnaire;
  • Have given written informed consent

Exclusion Criteria:

  • Age less than 18 or more than 80 years;
  • Pregnant or nursing women ;
  • Not being affiliated to the social security scheme;
  • Known allergy to local anesthetics of the amide type;
  • Regulatory constraints in the outpatient management of perineural catheters not respected:

    1. Inability of daily nursing care;
    2. No presence of a responsible adult at home the night of the intervention;
  • Scheduled hospital stay;
  • ASA physical status score (American Society of Anesthesiologists) above 3 or 3 unsteady;
  • Spontaneous request for continuous nerve block or single injection;
  • Topic unable to fulfill only a self-administered questionnaire (inability to read French, severe cognitive impairment);
  • Subject with cognitive impairment already documented (Alzheimer, dementia, neurological sequelae);
  • Topic treated with antipsychotics (neuroleptics or lithium);
  • Subject has a documented chronic pain syndrome;
  • Active consumer of narcotic topic;
  • Topic have not signed informed consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Electronic pump
Continuous nerve blocks Remote-controlled perineural local anesthetics delivery
Remote-controlled perineural local anesthetics delivery
No Intervention: single injection

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient experience and satisfaction scale (EVAN-G)
Time Frame: Second day after surgery
Description: Patient experience and satisfaction scale
Second day after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient quality of recovery (QoR)
Time Frame: First day after surgery
Description: Patient quality of recovery
First day after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Xavier CAPDEVILA, M.D., Ph.D., University Hospital, Montpellier

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 7, 2016

Primary Completion (Actual)

October 21, 2019

Study Completion (Actual)

December 2, 2019

Study Registration Dates

First Submitted

March 22, 2016

First Submitted That Met QC Criteria

March 25, 2016

First Posted (Estimate)

March 28, 2016

Study Record Updates

Last Update Posted (Actual)

April 3, 2020

Last Update Submitted That Met QC Criteria

April 1, 2020

Last Verified

March 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Orthopaedic Surgery

Clinical Trials on Remote-controlled perineural local anesthetics delivery

3
Subscribe